"Receptors, Interleukin-6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES, mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.
| Descriptor ID |
D019947
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.400
|
| Concept/Terms |
Receptors, Interleukin-6- Receptors, Interleukin-6
- Receptors, Interleukin 6
- IL-6 Receptors
- IL 6 Receptors
- Receptors, IL-6
- Receptors, IL 6
- IL6 Receptors
- Receptors, IL6
- Interleukin 6 Receptor
- Receptor, Interleukin 6
- Interleukin-6 Receptors
- Interleukin 6 Receptors
- IL-6 Receptor
- IL 6 Receptor
- Receptor, IL-6
- IL6 Receptor
- Receptor, IL6
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-6".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-6".
This graph shows the total number of publications written about "Receptors, Interleukin-6" by people in this website by year, and whether "Receptors, Interleukin-6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Interleukin-6" by people in Profiles.
-
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. N Engl J Med. 2021 04 22; 384(16):1503-1516.
-
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. 2021 01 01; 181(1):41-51.
-
Moderate dynamic compression inhibits pro-catabolic response of cartilage to mechanical injury, tumor necrosis factor-a and interleukin-6, but accentuates degradation above a strain threshold. Osteoarthritis Cartilage. 2013 Dec; 21(12):1933-41.
-
Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage. Arthritis Rheum. 2009 Oct; 60(10):2985-96.
-
Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem. 2002 May 10; 277(19):16879-87.
-
Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J. 2000 Aug; 14(11):1499-507.